SMN2 and proximal spinal muscular atrophy: Decision making on treatment options after NBS screening is based on presymptomatic diagnosis using SMN2 copy numbers, with a higher number of SMN2 copies generally correlating with reduced disease severity but imperfectly correlating with clinically defined SMA types [7].